KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 90 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,000 | – | 68 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $20,806,000 | 14.43% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $4,704,000 | 3.90% |
| Logos Global Management LP | 562,900 | $6,811,000 | 1.36% |
| Vivo Capital, LLC | 1,476,796 | $17,869,000 | 1.28% |
| Opaleye Management Inc. | 461,500 | $5,584,000 | 1.13% |
| Ghost Tree Capital, LLC | 350,000 | $4,235,000 | 1.12% |
| Ikarian Capital, LLC | 1,113,395 | $13,472,000 | 1.07% |
| DAFNA Capital Management LLC | 222,452 | $2,692,000 | 0.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $2,246,000 | 0.75% |
| Samsara BioCapital, LLC | 168,174 | $2,035,000 | 0.66% |